Related Experiment Video
Updated: May 29, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Herpes zoster infection, vaccination and immunocompromised rheumatology patients
Mortimer B O'Connor1, Mark J Phelan
1Department of Rheumatology, South Infirmary Victoria University Hospital, Cork, Ireland. mortimeroconnor@gmail.com
Abstract:
Varicella is a self-limiting and relatively mild disease of childhood, although it is frequently more severe and complicated among the immunocompromised rheumatology patients on immunomodulator therapies. In addition, future reactivation of the dormant virus in dorsal root ganglia may cause herpes zoster infection, which can be very debilitating. In this manuscript, we discuss the nature of this infection along with its potential vaccine especially among rheumatology patients.
Related Concept Videos
Chickenpox
Genital Herpes
Vaccinations
Herpes
Smallpox
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...

